Fidelity Investments
TENX icon

Fidelity Investments’s Tenax Therapeutics TENX Stock Holding History

Fidelity Investments’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.16M Buy
322,600
+181,500
+129% +$2.46M ﹤0.01% 2296
2025
Q4 		$1.72M Buy
+141,100
New +$1.23M ﹤0.01% 2664
2024
Q3 		– Sell
-1
Closed -$3 – 5723
2024
Q2 		$3 Buy
+1
New +$4 ﹤0.01% 5332

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fidelity Investments's TENX Position: Q1 2026 in Review

Fidelity Investments increased its Tenax Therapeutics (TENX) stake by 129% in Q1 2026, buying an estimated $2.46M and bringing the position to 322,600 shares worth $5.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2296.

Fidelity Investments first reported a position in TENX in Q2 2024 and has held it in 3 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Fidelity Investments held 322,600 shares of Tenax Therapeutics worth $5.16M as of Q1 2026.
  • Fidelity Investments bought 181,500 Tenax Therapeutics shares in Q1 2026, an estimated $2.46M.
  • Tenax Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2296 holding.
  • Fidelity Investments first reported a position in Tenax Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.